Solgate Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Seed
- Investors
-
5
Solgate General Information
Description
Operator of a biotechnology company intended to develop drugs against the solute gates to cure disease. The company focuses on membrane transporters known as solute carrier proteins and applies methods from chemistry, cell biology, and advanced analytics, developing an internal pipeline in specific therapeutic indications, including immunity, enabling pharmaceutical companies to find treatments for challenging diseases.
Contact Information
Website
www.solgate.comCorporate Office
- IST Park, Plöcking 1
- Klosterneuburg, Niederosterreich 3400
- Austria
Corporate Office
- IST Park, Plöcking 1
- Klosterneuburg, Niederosterreich 3400
- Austria
Solgate Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 26-Feb-2021 | Completed | Generating Revenue |
Solgate Patents
Solgate Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026202277-A1 | New heterocyclic compounds reducing the tasl protein level | Pending | 26-Mar-2025 | ||
| WO-2026202291-A1 | New heterocyclic compounds reducing the tasl protein level | Pending | 26-Mar-2025 | ||
| WO-2026202295-A1 | New heterocyclic compounds reducing the tasl protein level | Pending | 26-Mar-2025 | ||
| AU-2025261993-A1 | New heterocyclic compounds reducing the tasl protein level | Pending | 24-Apr-2024 | ||
| WO-2025224270-A1 | New heterocyclic compounds reducing the tasl protein level | Pending | 24-Apr-2024 | C07D215/52 |
Solgate Signals
Solgate Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Austria Wirtschaftsservice | Venture Capital | Minority | ||
| Lansdowne Capital | PE/Buyout | Minority | ||
| S-Quad Handels- und Beteiligungs | Family Office | Minority | ||
| Wlanholding | Family Office | Minority | ||
| Xista Science Ventures | Venture Capital | Minority |
Solgate FAQs
-
When was Solgate founded?
Solgate was founded in 2020.
-
Where is Solgate headquartered?
Solgate is headquartered in Klosterneuburg, Austria.
-
What is the size of Solgate?
Solgate has 31 total employees.
-
What industry is Solgate in?
Solgate’s primary industry is Biotechnology.
-
Is Solgate a private or public company?
Solgate is a Private company.
-
What is the current valuation of Solgate?
The current valuation of Solgate is .
-
What is Solgate’s current revenue?
The current revenue for Solgate is .
-
Who are Solgate’s investors?
Austria Wirtschaftsservice, Lansdowne Capital, S-Quad Handels- und Beteiligungs, Wlanholding, and Xista Science Ventures have invested in Solgate.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process